No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | mousehomozygous mutant ES cells |
AyuK12C12 |
Igsf9b-K1 |
mouse |
|
Homozygous mutant mouse embryonic stem cell. Deficient gene: Igsf9b |
|
2 | general cells |
IFO50005 |
J-111 |
human |
blood |
HeLa markers* |
|
3 | general cells |
IFO50008 |
Mm1 |
mouse |
bone marrow |
spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse) |
|
4 | general cells |
IFO50018 |
NIL |
hamster, Syrian |
embryo, whole |
transformed from hamster fibroblast |
|
5 | general cells |
IFO50037 |
RPMI 1788 |
human |
peripheral blood |
established from normal blood, IgM secreting |
|
6 | general cells |
IFO50042 |
C3H/MCA clone 15 |
mouse |
embryo |
Parent strain is C3H/10T/1/2 clone 8. |
|
7 | general cells |
IFO50046 |
Raji |
human |
maxilla |
lymphoma, Burkitt's |
|
8 | general cells |
IFO50153 |
A549 |
human |
lung |
adenocarcinoma |
|
9 | general cells |
IFO50267 |
PB-3c |
mouse |
bone marrow |
IL-3-dependent mouse bone marrow cell line. |
|
10 | general cells |
IFO50289 |
Becker |
human |
brain |
astrocytoma, GFAP-negative |
|
11 | general cells |
IFO50362 |
MOLT-4 |
human |
peripheral blood |
leukemia, acute T lymphoblastic |
|
12 | general cells |
IFO50375 |
MSS31 |
mouse |
spleen |
spleen stromal cell line, (C57BL/6 mouse) |
|
13 | general cells |
IFO50380 |
TLR3 |
mouse |
liver |
P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C. |
|
14 | general cells |
IFO50467 |
NMC-G1 |
human |
brain |
glioma, FGF-9-producing |
|
15 | general cells |
IFO50477 |
FS-1 |
human |
bone marrow stroma |
This cell line produces IL-6 and SCF into its supernatant. Although this cell line was reported as immortalized cell line, the ampoules preserved in the cell bank hardly proliferated. |
|
16 | general cells |
IFO50478 |
MEG-A2 |
human |
peripheral blood |
This cell line is useful for studying the differentiation and maturation of megakaryocyts. |
|
17 | general cells |
JCRB0013 |
16-8 |
mouse |
spleen |
Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. |
|
18 | general cells |
JCRB0019 |
K562 |
human |
pleural effusion |
Highly undifferentiated and granurocytic myelogenous leukemia cell line from blast crisis. |
|
19 | general cells |
JCRB0024 |
IM-9 |
human |
bone marrow |
myeloma, multiple, B lymphoblastic |
|
20 | general cells |
JCRB0071 |
BALL-1 |
human |
peripheral blood |
Acute lymphoblastoid leukemia (ALL) cell line from human. |
|
21 | general cells |
JCRB0084 |
4-2D |
mouse |
NS1 x spleen cell |
anti-primase complexed with DNA polymerase alpha |
|
22 | general cells |
JCRB0121 |
YG10008 |
hamster, Chinese |
lung |
human polymorphic N-acetyltransferase gene transfected CHL cells |
|
23 | general cells |
JCRB0129.1 |
RCR-1 |
rat |
brain |
Rat astrocyte-like cells producing GFAP. Serum free cell line (RCR-1.P3) is also available. |
|
24 | general cells |
JCRB0132.1 |
AH601(JTC27) |
rat |
ascites |
A transplantable rat hepatoma cell line derived from ascites. |
|
25 | general cells |
JCRB0144.1D |
LYM-1.P3D |
rat |
lymph node near colon cancer |
Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. |
|
26 | general cells |
JCRB0147 |
JKT-beta-del |
human |
blood |
The JKT-beta-del cell line isolated from the Jurkat cells{5011} by a cell sorter and lacks the surface expression of the T-cell receptor alpha/beta/CD3 complex. |
|
27 | general cells |
JCRB0153.3 |
tsJT60 |
rat |
embryo |
Rat 3Y1 derived ts mutant cell line with cell cycle arrest at G0 phase. |
|
28 | general cells |
JCRB0154 |
NB(TU)1-10 |
human |
adrenal grand |
Humn neuroblastoma(stageIII) cell line from abdominal tumor with N-myc aberration. |
|
29 | general cells |
JCRB0163 |
HL60(S) |
human |
peripheral blood |
Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K. |
|
30 | general cells |
JCRB0199 |
huH-1 |
human |
liver |
Human hepatoma cell line. |
|
31 | general cells |
JCRB0200 |
KMLS-1 |
human |
|
liposarcoma |
|
32 | general cells |
JCRB0208 |
CCK-81 |
human |
colon |
adenocarcinoma |
|
33 | general cells |
JCRB0405 |
HLF |
human |
liver |
hepatoma, non-differentiated |
|
34 | general cells |
JCRB0601 |
BALB/3T3 A31-1-1 |
mouse |
embryo |
fibroblast, contact inhibited, (Strain problem was found. Refer Important Notice at cell detail page.) |
|
35 | general cells |
JCRB0650.1 |
Mm2T12.P3 |
Indian Muntjak |
thymus |
Serum free subline from Mm2T cells. |
|
36 | general cells |
JCRB0701 |
FM3A |
mouse |
mammary gland |
mammary carcinoma, spontaneously obtained, (C3H/He mouse) |
|
37 | general cells |
JCRB0714.1 |
AH-7974.P3 |
rat |
ascites |
Serum free rat ascited hepatoma cell line. Cells have been maintained by passage for long time. Extremely high passage number. |
|
38 | general cells |
JCRB0746 |
YKG-1 |
human |
brain |
glioblastoma |
|
39 | general cells |
JCRB0822 |
NUGC-3 |
human |
stomach |
adenocarcinoma, poorly differentiated |
|
40 | general cells |
JCRB1006.8F |
OUMS-36T-8F |
human |
embryo |
fibroblast, immortalized by hTRT, derivative of OUMS-36 |
|
41 | general cells |
JCRB1012 |
KMRC-3 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. The growth is extremely slow. |
|
42 | general cells |
JCRB1044 |
OVKATE |
human |
ovary |
Human cell line derived from ovarian tumor. |
|
43 | general cells |
JCRB1065 |
Ki-JK |
human |
pleural fluid |
Human mononuclear cells with multiple nucleoli from lymphoma patient. |
|
44 | general cells |
JCRB1092 |
NCE SVIA6 |
human |
cervix |
SV40 transformed human keratinocyte cell line. |
|
45 | general cells |
JCRB1103 |
cs-19-36 |
hamster, Chinese |
lung |
Temperature sensitive mutant of Chinese hamster lung cell line. |
|
46 | general cells |
JCRB1132 |
KUSA-0 |
mouse |
Bone marrow |
Mouse osteoblastic cell line. |
|
47 | general cells |
JCRB1134 |
KUM3 |
mouse |
Bone marrow |
Osteoblast cell line from Mouse C3H bone marrow. |
|
48 | general cells |
JCRB1135 |
KUM4 |
mouse |
Bone Marrow |
Osteoblastic cell line of mouse C3H. |
|
49 | general cells |
JCRB1151 |
UE6E7T-12 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
50 | general cells |
JCRB1176 |
KUM10 |
mouse |
bone marrow |
Osteoblast cell line from mouse C57/B6 bone marrow. |
|
51 | general cells |
JCRB1180 |
KMM-1 |
human |
subcutaneous tumor |
human myeloma cell line |
|
52 | general cells |
JCRB1206 |
TK |
human |
brain tumor |
Brain lymphoma cell line. |
|
53 | general cells |
JCRB1213.2 |
DIG222.4D.5 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against digoxin. |
|
54 | general cells |
JCRB1222.03 |
HGH1.17.2 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
55 | general cells |
JCRB1222.12 |
HGH1.31.3 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
56 | general cells |
JCRB1304 |
MT-45-5-3 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against metallothionein. |
|
57 | general cells |
JCRB1342.02 |
MOR35.4.12 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
58 | general cells |
JCRB1342.06 |
MOR115.1.13 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
59 | general cells |
JCRB1342.08 |
MOR131.5.13 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
60 | general cells |
JCRB1370 |
TAS-5 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/VCAM-1 and VLA-4/Fibronectin |
|
61 | luciferase-expressing cancer cells |
JCRB1388 |
A-498-Luc |
human |
kidney |
Luciferase stably expressing cell line (A-498; Human Renal Cancer). |
|
62 | general cells |
JCRB1403 |
Kasumi-8 |
human |
blood |
B cell leulemia |
|
63 | general cells |
JCRB1415 |
KasumiA-568 |
human |
blood |
myeloblastic leukemia |
|
64 | luciferase-expressing cancer cells |
JCRB1478 |
NCI-H1650-Luc |
human |
pleural effusion |
Luciferase stably expressing cell line (NCI-H1650; Human lung adenocarcinoma cell line). |
|
65 | genetically-modified cells |
JCRB1489 |
POLZ D2781N |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low activity, TK+/-) |
|
66 | genetically-modified cells |
JCRB1490 |
POLZ L2618M |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) |
|
67 | genetically-modified cells |
JCRB1515 |
POLZ L2618F |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) |
|
68 | genetically-modified cells |
JCRB1535 |
TBK1-DEF |
mouse |
embryo |
Mouse embryonic fibroblasts prepared from TANK-binding kinase 1 (TBK1) deficient mice. |
|
69 | general cells |
JCRB1621 |
hTf2-9F/sf |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
70 | general cells |
JCRB1657 |
HuCCA-1 |
human |
intrahepatic bile duct |
Human cell line derived from cholangiocarcinoma. |
|
71 | general cells |
JCRB1748 |
XYFMGG06K |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
72 | general cells |
JCRB1753 |
XYFMGC44W |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
73 | general cells |
JCRB1772 |
KKU-452 |
human |
|
Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. |
|
74 | general cells |
JCRB1779 |
KKK-D138 |
human |
intrahepatic bile duct |
Human adenosquamous carcinoma cell line established from biliary tract. |
|
75 | general cells |
JCRB1780 |
BLACK-93A |
human |
Pleural effusion |
Burkitt lymphoma cell line. |
|
76 | general cells |
JCRB1790 |
BALM-9N |
human |
peripheral blood |
B cell leukemia cell line |
|
77 | general cells |
JCRB1796 |
BALM-18 |
human |
peripheral blood |
B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;14)(q24;q32) |
|
78 | genetically-modified cells |
JCRB1838 |
HeLa-TMPRSS2 |
human |
cervix |
HeLa cells expressing the transmembrane serine protease TMPRSS2. Recommended use: Isolation of human coronavirus 229E (HCoV-229E) |
|
79 | general cells |
JCRB1847 |
MOTN-1 |
human |
perpheral blood |
T-cell large granular lymphocyte leukemia cell line. |
|
80 | general cells |
JCRB1852 |
Cx43KOM104-E6(-/-) |
mouse |
embryo, whole |
Connexin 43 -/- mouse embryo-derived fibroblast cell line. (embryo from Connexin 43 +/- parents) |
|
81 | general cells |
JCRB1863 |
NALM-36 |
human |
perpheral blood |
B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-37 |
|
82 | general cells |
JCRB1873 |
HSC-44PE |
human |
pleural effusion |
Human signet ring cell gastric carcinoma cell line. Established from tumor cells in pleural effusion. |
|
83 | general cells |
JCRB1887 |
KE-4 |
human |
esophaqus |
Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
84 | general cells |
JCRB1913 |
Me1Tu |
human |
|
Transplanted cell line of malignant pleural mesothelioma TCC-MESO-1 into SCID mice. |
|
85 | general cells |
JCRB1915 |
KE-6 |
human |
esophagus |
Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
86 | genetically-modified cells |
JCRB1961 |
MDCK-dTGFalpha |
dog |
kidney |
Transforming growth factor alpha (TGFalpha)-deficient MDCK cell line. |
|
87 | genetically-modified cells |
JCRB1967 |
MDCK-DKO |
dog |
kidney |
Epidermal growth factor (EGF) and heparin-binding EGF (HBEGF)-double deficient MDCK cell line.
|
|
88 | genetically-modified cells |
JCRB1973 |
MDCK-EKARrEV-NLS |
dog |
kidney |
MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
89 | genetically-modified cells |
JCRB1980 |
MDCK-EKARrEV-NLS-dEREG |
dog |
kidney |
epiregulin (EREG)-deficient MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
90 | genetically-modified cells |
JCRB1993 |
MDCK-WT-EKARrEV-NLS-LDR |
dog |
kidney |
MDCK cell line expressing FRET biosensor EKARrEV-NLS and Lyn-targeted FRB (LDR). |
|
91 | genetically-modified cells |
JCRB1994 |
MDCK-EKARrEV-NLS- dEGFR |
dog |
kidney |
epidermal growth factor receptor (EGFR)-deficient MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
92 | genetically-modified cells |
JCRB1996 |
MDCK-dADAM17-EKARrEV-NLS |
dog |
kidney |
A disintegrin and metalloprotease 17 (ADAM17)-deficient MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
93 | general cells |
JCRB2207 |
A9(Neo7) |
human chromosome-introduced |
skin |
contains human chromosome # 7 (MTA with Tottori Univ. is required.) |
|
94 | general cells |
JCRB2222 |
A9(Hygro22) |
human chromosome-introduced |
skin |
contains human chromosome #22 (MTA with Tottori Univ. is required.) |
|
95 | general cells |
JCRB9065 |
G-401 |
human |
kidney |
Rhabdoid tumor of kidney (formerly classified as Wilms' tumor) |
|
96 | general cells |
JCRB9076 |
FHs 74 Int |
human |
small intestine |
Human fetal small intestine cells (not the intestinal epithelial cells). The growth is very slow. |
|
97 | general cells |
JCRB9095 |
HEPM |
human |
embryo |
embryonic palatal mesenchyme, limited life span |
|
98 | general cells |
JCRB9101 |
CCD-14Br |
human |
bronchiole |
bronchus, diploid |
|
99 | general cells |
JCRB9103 |
KD |
human |
lip |
fibroblast, lip |
|
100 | general cells |
JCRB9111 |
BeWo |
human |
fetal placenta |
Human placenta derived cell line. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.